BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 24373505)

  • 1. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
    Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
    PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
    Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
    Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
    Tsonis AI; Zisimopoulou P; Lazaridis K; Tzartos J; Matsigkou E; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Tzartos SJ
    J Neuroimmunol; 2015 Jul; 284():10-7. PubMed ID: 26025053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
    Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
    Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R; Motomura M
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies in myasthenia gravis].
    Motomura M; Narita Masuda T
    Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.
    Stergiou C; Lazaridis K; Zouvelou V; Tzartos J; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Gilhus NE; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Bogomolovas J; Labeit D; Labeit S; Tzartos SJ
    J Neuroimmunol; 2016 Mar; 292():108-15. PubMed ID: 26943968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
    Huda S; Woodhall MR; Vincent A; Heckmann JM
    Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
    Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
    Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
    Pevzner A; Schoser B; Peters K; Cosma NC; Karakatsani A; Schalke B; Melms A; Kröger S
    J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and clinical classification of autoimmune myasthenia gravis.
    Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
    J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-agrin autoantibodies in myasthenia gravis.
    Gasperi C; Melms A; Schoser B; Zhang Y; Meltoranta J; Risson V; Schaeffer L; Schalke B; Kröger S
    Neurology; 2014 Jun; 82(22):1976-83. PubMed ID: 24793185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
    Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG
    J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis.
    Li Y; Zhang Y; Cai G; He D; Dai Q; Xu Z; Chu L
    Muscle Nerve; 2017 Nov; 56(5):938-942. PubMed ID: 28120340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
    Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
    Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.